In particular, the Wee1 inhibitor MK-1775 has been found efficient to eliminate a number of cancer cell species [3, 4], and it is currently evaluated in numerous clinical trials ([5] and 21 entries to clinicaltrial.gov). The gene discussed is WEE1; the disease is cancer.